-
Russia approves first drug against Ankylosing Spondylitis
25 Apr 2024 15:32 GMT
… out that the new drug destroys pathological T lymphocytes … Organization (WHO), the drug is the result of … pharmaceutical company BIOCAD.
One of the creators of the drug, … drug can be launched into production.
Ankylosing Spondylitis, also known as Bechterew- …
-
Ont. teacher says she's being forced to switch pharmacies to maintain medication coverage
24 Apr 2024 23:03 GMT
… ,” Miller says.
The medication she takes to treat ankylosing spondylitis, a type of arthritis … of these high-cost speciality drugs.”
Miller admits she’s known … members require MemberRx pharmacy support for their specialty drug needs. For the …
-
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
26 Apr 2024 05:59 GMT
… psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative … treatment and their eczema is not well controlled with other pills … drugs to the FDA. Visit www.fda.gov … Prescribing Information and Medication Guide.
Globally, …
-
UCB’s Bimzelx granted EC approval to treat hidradenitis suppurativa in adults
23 Apr 2024 11:28 GMT
… Commission (EC) to treat active moderate-to-severe … to treat plaque psoriasis, psoriatic arthritis and axial spondyloarthritis.
The … maintained to week 48.
Treatment with Bimzelx also resulted …
Pooled data for the drug from treatment initiation to four years …
-
European Union Approves Bimekizumab to Treat HS
22 Apr 2024 14:18 GMT
… FDA for psoriatic arthritis, non-radiographic axial spondyloarthritis, ankylosing spondylitis, … development aligns with UCB's overarching goal of broadening treatment … drugs do come to market to figure out which drug … whole bunch of medications back-to-back …
-
Booming Global Autoimmune Disease Testing Market, Global Size to Hit USD 24.14 billion by 2031
25 Apr 2024 15:46 GMT
… diagnosis and personalized treatment approaches has bolstered … with research and development: The development of innovative … Rheumatoid arthritis
- Ankylosing spondylitis
- Systemic Lupus Erythematosus … • Company B received FDA approval in January 2023 …
-
Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis
25 Apr 2024 08:08 GMT
… subjects, 2.88%), and ankylosing spondylitis (AS) (1 subject, … early diagnosis and prompt treatment of other non- … manifestations. J Clin Med. 2021;10(11):2235 … al. The development of assessment of spondyloarthritis international society classification …
-
Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies
25 Apr 2024 03:19 GMT
… MCTD), rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, systemic lupus … for efficient treatments.
Furthermore, the development of a new … . Breast Cancer Res Treat. 2016;157:55–63 … biliary cirrhosis. Aliment. Pharmacol. Ther. 2006;24( …
-
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
24 Apr 2024 08:00 GMT
… . All three study treatments were given at a … arthritis, psoriatic arthritis, and ankylosing spondylitis [2]. AVT05 is … biosimilar candidates aimed at treating autoimmune disorders, eye … Med Pro (Australia, New Zealand, South Africa/Africa), JAMP Pharma …
-
Risankizumab Significantly Improves Skin, Joint Symptoms in PsA
22 Apr 2024 22:22 GMT
Among a cohort of patients with psoriatic arthritis (PsA), treatment with risankizumab, an interleukin (IL)-23 inhibitor, was shown to disease activity and improve skin involvement, according to a study published in International Journal of Dermatology.1
…